OR WAIT null SECS
May 16, 2018
The company is increasing its cell culture media production capacity at its facilities in Pasching, Austria, and Logan, Utah.
Valerius Biopharma will use Catalent’s GPEx technology to produce cell lines for biosimilar drugs.
ExcipientFest has been acquired by IPEC and rebranded as Excipient World.
May 15, 2018
Naturally occurring and engineered albumins are being explored as a tool to enhance the stability of drugs, including biologics, and extend shelf-life.
May 14, 2018
Barriers impede biosimilar market entry into the United States despite the Biologics Price Competition and Innovation Act.
May 10, 2018
The companies have extended a contract agreement for the commercial manufacture of the active pharmaceutical ingredient for vonapanitase, an investigational drug intended to improve hemodialysis vascular access outcomes.
May 02, 2018
Choice of carrier can have a significant impact on the capsule filling process as well as the performance of the DPI formulation.
Bioprocess understanding, the right equipment, and automation help, but multifunctional teamwork is the key to API production success.
April 24, 2018
Porton will use biocatalyst technologies from Codexis to accelerate API development for clients.
April 20, 2018
The new platform is expected to speed up cell line development.
